INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $115,519 | +19.7% | 4,575 | 0.0% | 0.10% | +31.5% |
Q2 2023 | $96,533 | +23.8% | 4,575 | 0.0% | 0.07% | +19.7% |
Q1 2023 | $78,004 | -14.7% | 4,575 | 0.0% | 0.06% | -11.6% |
Q4 2022 | $91,409 | -7.7% | 4,575 | 0.0% | 0.07% | -18.8% |
Q3 2022 | $99,000 | +10.0% | 4,575 | 0.0% | 0.08% | +18.1% |
Q2 2022 | $90,000 | -16.7% | 4,575 | 0.0% | 0.07% | 0.0% |
Q1 2022 | $108,000 | -13.6% | 4,575 | 0.0% | 0.07% | -8.9% |
Q4 2021 | $125,000 | -10.7% | 4,575 | -10.1% | 0.08% | -23.3% |
Q3 2021 | $140,000 | +2.2% | 5,089 | +1.4% | 0.10% | +2.0% |
Q2 2021 | $137,000 | +522.7% | 5,019 | +675.7% | 0.10% | +461.1% |
Q1 2021 | $22,000 | -26.7% | 647 | -28.6% | 0.02% | -30.8% |
Q4 2020 | $30,000 | -76.9% | 906 | -77.5% | 0.03% | -77.8% |
Q3 2020 | $130,000 | +622.2% | 4,035 | +503.1% | 0.12% | +485.0% |
Q2 2020 | $18,000 | +200.0% | 669 | +67.2% | 0.02% | +185.7% |
Q1 2020 | $6,000 | -33.3% | 400 | 0.0% | 0.01% | -30.0% |
Q4 2019 | $9,000 | – | 400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |